These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 22552006)

  • 21. Paradigm of kinase-driven pathway downstream of epidermal growth factor receptor/Akt in human lung carcinomas.
    Dobashi Y; Suzuki S; Kimura M; Matsubara H; Tsubochi H; Imoto I; Ooi A
    Hum Pathol; 2011 Feb; 42(2):214-26. PubMed ID: 21040950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers.
    Zhou X; Tan M; Stone Hawthorne V; Klos KS; Lan KH; Yang Y; Yang W; Smith TL; Shi D; Yu D
    Clin Cancer Res; 2004 Oct; 10(20):6779-88. PubMed ID: 15501954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antihormonal therapy in breast cancer and mTOR inhibitors].
    Heudel PÉ; Tredan O; Ray-Coquard I; Treilleux I; Guastalla JP; Bachelot T
    Bull Cancer; 2011 Dec; 98(12):1431-7. PubMed ID: 22133994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma.
    Rudelius M; Pittaluga S; Nishizuka S; Pham TH; Fend F; Jaffe ES; Quintanilla-Martinez L; Raffeld M
    Blood; 2006 Sep; 108(5):1668-76. PubMed ID: 16645163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapamycin allosterically inhibits the proteasome.
    Osmulski PA; Gaczynska M
    Mol Pharmacol; 2013 Jul; 84(1):104-13. PubMed ID: 23619386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mantle cell lymphoma: taking therapeutic advantage of new insights into the biology.
    Tang T; Martin P
    Curr Hematol Malig Rep; 2014 Sep; 9(3):254-61. PubMed ID: 25023397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combinatorial drug screening identifies synergistic co-targeting of Bruton's tyrosine kinase and the proteasome in mantle cell lymphoma.
    Axelrod M; Ou Z; Brett LK; Zhang L; Lopez ER; Tamayo AT; Gordon V; Ford RJ; Williams ME; Pham LV; Weber MJ; Wang ML
    Leukemia; 2014 Feb; 28(2):407-10. PubMed ID: 23979520
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapeutic activity of mTOR inhibitors in mantle cell lymphoma: clues but no clear answers.
    Younes A
    Autophagy; 2008 Jul; 4(5):707-9. PubMed ID: 18469512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The HIV protease inhibitor nelfinavir downregulates Akt phosphorylation by inhibiting proteasomal activity and inducing the unfolded protein response.
    Gupta AK; Li B; Cerniglia GJ; Ahmed MS; Hahn SM; Maity A
    Neoplasia; 2007 Apr; 9(4):271-8. PubMed ID: 17460771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AKT/mTORC pathway in antiphospholipid-related vasculopathy: a new player in the game.
    Canaud G; Legendre C; Terzi F
    Lupus; 2015 Mar; 24(3):227-30. PubMed ID: 25631854
    [No Abstract]   [Full Text] [Related]  

  • 31. [New insights in the antiphospholipid syndrome associated vasculitis: the role of the AKT/mTORC pathway].
    Canaud G
    Rev Med Interne; 2015 Jul; 36(7):439-43. PubMed ID: 25769629
    [No Abstract]   [Full Text] [Related]  

  • 32. Links between mTOR and the immunoproteasome: Therapeutic targets for cardiac hypertrophy?
    Ackermann MA
    J Mol Cell Cardiol; 2015 Dec; 89(Pt B):113-5. PubMed ID: 26409046
    [No Abstract]   [Full Text] [Related]  

  • 33. mTOR inhibits starvation-induced nuclear export of the proteasome.
    Baumann K
    Nat Rev Mol Cell Biol; 2023 Dec; 24(12):854. PubMed ID: 37803206
    [No Abstract]   [Full Text] [Related]  

  • 34. Proteasome inhibition by new dual warhead containing peptido vinyl sulfonyl fluorides.
    Brouwer AJ; Herrero Álvarez N; Ciaffoni A; van de Langemheen H; Liskamp RM
    Bioorg Med Chem; 2016 Aug; 24(16):3429-35. PubMed ID: 27316540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rac1 is a novel therapeutic target in mantle cell lymphoma.
    Tian T; Bi C; Hein AL; Zhang X; Wang C; Shen S; Yuan J; Greiner TC; Enke C; Vose J; Yan Y; Fu K
    Blood Cancer J; 2018 Feb; 8(2):17. PubMed ID: 29434202
    [No Abstract]   [Full Text] [Related]  

  • 36. Stabilization of DEPTOR sensitizes hypopharyngeal cancer to radiotherapy via targeting degradation.
    Wang X; Cao Z; Yue X; Liu T; Wen G; Jiang D; Wu W; Le L; Wang Y; Wang C; Wang Z; Jin M; Zhu M; He S; Zhang X; Bu X; Liu RY; Peng Z; Chen Y
    Mol Ther Oncolytics; 2022 Sep; 26():330-346. PubMed ID: 36090478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein targeting chimeric molecules specific for bromodomain and extra-terminal motif family proteins are active against pre-clinical models of multiple myeloma.
    Zhang X; Lee HC; Shirazi F; Baladandayuthapani V; Lin H; Kuiatse I; Wang H; Jones RJ; Berkova Z; Singh RK; Lu J; Qian Y; Raina K; Coleman KG; Crews CM; Li B; Wang H; Hailemichael Y; Thomas SK; Wang Z; Davis RE; Orlowski RZ
    Leukemia; 2018 Oct; 32(10):2224-2239. PubMed ID: 29581547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MLN4924, an NAE inhibitor, suppresses AKT and mTOR signaling via upregulation of REDD1 in human myeloma cells.
    Gu Y; Kaufman JL; Bernal L; Torre C; Matulis SM; Harvey RD; Chen J; Sun SY; Boise LH; Lonial S
    Blood; 2014 May; 123(21):3269-76. PubMed ID: 24713927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of PI-1840, a novel noncovalent and rapidly reversible proteasome inhibitor with anti-tumor activity.
    Kazi A; Ozcan S; Tecleab A; Sun Y; Lawrence HR; Sebti SM
    J Biol Chem; 2014 Apr; 289(17):11906-11915. PubMed ID: 24570003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding the interplay between the proteasome pathway and autophagy in response to dual PI3K/mTOR inhibition in myeloma cells is essential for their effective clinical application.
    Aronson LI; Davenport EL; Mirabella F; Morgan GJ; Davies FE
    Leukemia; 2013 Dec; 27(12):2397-403. PubMed ID: 23670295
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.